Are more tests needed? [0.03%]
还需要更多的测试吗？
Norman M Kaplan
Norman M Kaplan
Identifying early cardiovascular disease to target candidates for treatment [0.03%]
识别早期心血管疾病以确定治疗对象
Daniel A Duprez,Jay N Cohn
Daniel A Duprez
Most attempts to identify individuals at risk for cardiovascular morbid events have involved screening for risk factors. These traditional risk factors do not identify the underlying atherosclerotic disease nor assess the severity of diseas...
Prevention of cardiovascular events by treating hypertension in older adults: an evidence-based approach [0.03%]
基于证据的降压治疗预防老年人心血管事件发生的研究
Muhammad Firdaus,Chittur A Sivaram,Dwight W Reynolds
Muhammad Firdaus
Hypertension in older adults is not well controlled in clinical practice. Isolated systolic hypertension is often more difficult to manage. A systematic PubMed search was conducted to look for evidence showing benefits of lowering blood pre...
Escalating antihypertensive medications in end-stage renal disease patients does not improve blood pressure control [0.03%]
对于终末期肾病患者来说增加降压药物并不能改善血压控制状况
Mihály Tapolyai,Jariatul Karim,Atif Fakhruddin
Mihály Tapolyai
The authors examined the efficacy of antihypertensive medication use in end-stage renal disease (ESRD). They compared achieved blood pressures (BPs) in a cross-sectional study of 106 ESRD patients whose medications had not been changed for ...
Mail education is as effective as in-class education in hypertensive Korean patients [0.03%]
韩国高血压患者的邮件教育与课堂教育一样有效
Miyong T Kim,Eun-Young Kim,Hae-Ra Han et al.
Miyong T Kim et al.
Many Korean American persons have hypertension, but competing life priorities often prevent them from attending health-promotion educational activities. Using principles of community-based participatory research, the authors conducted a pro...
Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with the metabolic syndrome: data from the SARA Study [0.03%]
代谢综合征高血压患者应用基于血管紧张素受体阻滞剂方案使左室肥厚逆转：源自SARA研究的资料
Carlos Escobar,Vivencio Barrios,Alberto Calderón et al.
Carlos Escobar et al.
The authors assessed the effect of an angiotensin receptor blocker (candesartan)-based regimen on electrocardiographic left ventricular hypertrophy (ECG-LVH) in 276 patients with hypertension, including 141 with the metabolic syndrome (MS)....
Beneficial effect of angiotensin II type 1 receptor blocker antihypertensive treatment on arterial stiffness: the role of smoking [0.03%]
血管紧张素Ⅱ受体拮抗剂降压治疗对动脉僵硬度的有益影响：吸烟的作用
Gregory P Vyssoulis,Eva A Karpanou,Stella-Maria G Kyvelou et al.
Gregory P Vyssoulis et al.
The purpose of the present study was to assess angiotensin receptor blocker (ARB) treatment on arterial stiffness in select hypertensive patients and define possible differences between smokers and nonsmokers. The authors evaluated 81 conse...
Controlled Clinical Trial
Journal of clinical hypertension (Greenwich, Conn.). 2008 Mar;10(3):201-7. DOI:10.1111/j.1751-7176.2008.07141.x 2008
Can ischemic stroke be caused by acute reduction of blood pressure in the acute phase of cardiovascular disease? [0.03%]
心血管病急性期血压急骤下降可引起脑梗死吗？
Satoshi Hoshide,Kazuo Eguchi,Joji Ishikawa et al.
Satoshi Hoshide et al.
Acute-phase cardiovascular disease (CVD) frequently presents with markedly elevated blood pressure (BP) levels and often requires fairly rapid lowering of BP. On the other hand, aggressive lowering of systemic BP to the point that the cereb...
Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: the Exforge in Failure after Single Therapy (EX-FAST) study [0.03%]
高血压单药治疗失效患者中苯磺酸氨氯地平片联合缬沙坦治疗的有效性：EX-FAST研究
Yves Allemann,Belen Fraile,Michel Lambert et al.
Yves Allemann et al.
In this randomized, double-blind, multicenter study, patients whose blood pressure (BP) was uncontrolled by monotherapy were switched directly to amlodipine/valsartan 5/160 mg (n=443) or 10/160 mg (n=451). After 16 weeks, BP control (levels
Randomized Controlled Trial
Journal of clinical hypertension (Greenwich, Conn.). 2008 Mar;10(3):185-94. DOI:10.1111/j.1751-7176.2008.07516.x 2008
Joseph L Izzo Jr
Joseph L Izzo Jr